Biotech of the Week: Zealand Pharma, Biotech Success Story made in Denmark

11/12/2015 - 2 minutes

This week we say farewell to Zurich and head North, through Germany where we arrive at our next destination, the capital city of Denmark, Copenhagen. This amazing city is famous for the Little Mermaid Statue, the autonomous neighborhood of Christiania and Tivoli Gardens Amusement Park. It is also home to our biotech of the week: Zealand Pharma.

Zealand Pharma Logo

City: Copenhagen

Founded: 1998

Financial Data: €3.52B Market Cap (on 11/2015)

Employees: 112 (as of 12/2015)


Mission: Zealand Pharma is a biotech company that has the primary mission to turn peptides into medicines. They focus on diseases which they believe current treatments fail the patient’s medical needs and could benefit from peptide-based medicines. The company focuses on 3 therapeutic areas: metabolic, gastrointestinal and cardiovascular diseases. At present, Zealand has one marketed product through a development partnership with Sanofi, Lixisenatide, a treatment of type II diabetes, along with several phase III products and multiple phase I/II in its partnered pipeline and its own proprietary pipeline. 

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
Do you want to remove this advert? Become a member!
Do you want to remove this advert? Become a member!